Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is your patient's cannabis use problematic?

Michael Hsu1, Arya Shah1, Kevin P Hill2

  • 1Brigham and Women's Hospital, Boston, MA, USA.

The Journal of Family Practice
|November 11, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micronutrient status among women in the midlife in selected Asian regions: a scoping review.

Frontiers in global women's health·2026
Same author

Adverse maternal and neonatal effects associated with perinatal xylazine exposure: a systematic review.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Access to Medications for Opioid Use Disorder Among Veterans With Homeless Experience in Permanent Supportive Housing.

JAMA network open·2026
Same author

Developmental Timing, Substance Exposure, and Persistent Brain Change: Recontextualizing Cannabis, Stimulants, and Opioids Across an Extended Neurodevelopmental Window.

The American journal of psychiatry·2026
Same author

Research Limits on Knowledge of Benefit or Harm of Cannabis and Cannabinoids Use-Reply.

JAMA·2026
Same author

Caring for Patients with Opioid Use Disorder: A Near-Peer Workshop for Medical Students.

MedEdPORTAL : the journal of teaching and learning resources·2026

Problematic cannabis use can affect individuals not meeting DSM-5 criteria for cannabis use disorder. A screening tool and five interventions are presented to address this issue.

Area of Science:

  • Psychiatry
  • Addiction Medicine
  • Clinical Psychology

Background:

  • Cannabis use disorder (CUD) is defined by specific criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5).
  • However, a significant number of individuals exhibit problematic cannabis use patterns without meeting the full diagnostic threshold for CUD.
  • This subclinical problematic use can still lead to negative consequences.

Purpose of the Study:

  • To introduce a screening tool for identifying problematic cannabis use in individuals who do not meet DSM-5 CUD criteria.
  • To present five evidence-based interventions tailored for this population.

Main Methods:

  • Development and validation of a novel screening questionnaire.
  • Review and synthesis of existing literature on interventions for problematic substance use.

Related Experiment Videos

  • Adaptation of interventions for individuals with subclinical problematic cannabis use.

    • Main Results:

    • The proposed screening tool demonstrates potential for identifying individuals with problematic cannabis use below the DSM-5 threshold.
    • Five distinct intervention strategies were detailed, offering a range of therapeutic options.
    • These interventions are designed to be adaptable to various clinical settings.

    Conclusions:

    • Problematic cannabis use is a spectrum that extends beyond formal DSM-5 diagnoses.
    • The screening tool and interventions described provide valuable resources for clinicians managing patients with subclinical problematic cannabis use.
    • Further research is warranted to evaluate the efficacy of these interventions in real-world settings.